SCHEMBL16626746

SCHEMBL16626746

CNCc1cn(S(=O)(=O)c2cccc(C(F)(F)F)c2)c2cc(Nc3ccc(OC(F)(F)F)cc3OC)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.41
HTR6 P50406 6/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
PPARG P37231 2/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ALOX15 P16050 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CNR2 P34972 2/20 0.37
EPHX2 P34913 1/20 0.37
CYSLTR1 Q9Y271 1/20 0.37
SLC20A2 Q08357 1/20 0.37
SLC20A1 Q8WUM9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618727 0.99 RORC (0.41) RORCHTR6GAAMAPTLMNA
SCHEMBL16626724 0.94 FBP1 (0.40) HTR6PPARGPPARDPPARACNR2
SCHEMBL17971561 0.94 HTR6 (0.43) RORCHTR6GAAMAPTLMNA
Hydrochloric Acid SCHEMBL16619005 0.94 FBP1 (0.40) HTR6PPARGPPARDPPARACNR2
SCHEMBL17971564 0.93 FBP1 (0.43) HTR6PPARGPPARDPPARACNR2
SCHEMBL17975820 0.91 RORC (0.42) RORCHTR6PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL16619295 0.90 RORC (0.42) RORCHTR6PPARGPPARDPPARA
SCHEMBL16626439 0.88 LMNA (0.39) HTR6LMNATSHRPPARGPPARD
Hydrochloric Acid SCHEMBL16619117 0.87 LMNA (0.38) HTR6LMNATSHRPPARGPPARD
SCHEMBL16626503 0.87 HTR6 (0.43) RORCHTR6GAAMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI RORC 1067/4885HTR6 166/4885GAA 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.